Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue

American Journal of Pathology

Volumn 150, Issue 4, 1997, Pages 1231-1244

  Luther, Thomas ^a   Magdolen, Viktor ^b,c   Albrecht, Sybille ^a   Kasper, Michael ^a   Riemer, Christoph ^b   Kessler, Horst ^b   Graeff, Henner ^b   Müller, Martin ^a   Schmitt, Manfred ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; RECEPTOR; UROKINASE;

ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER INVASION; CYTOFLUOROMETRY; EPITOPE MAPPING; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; CARCINOMA; CHO CELLS; CRICETINAE; EPITOPE MAPPING; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MICE, INBRED BALB C; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 0030945032     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Kohn EC, Liotta LA: Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995, 55:1856-1862
2. Schmitt M, Thomssen C, Jänicke F, Höfler H, Ulm K, Magdolen V, Reuning U, Wilhelm O, Graeff H: Clinical significance of the serine protease uPA (urokinase) and its inhibitor PAI-1 as well as the cysteine proteases cathepsin B and L in breast cancer. Breast Cancer: Advances in Biology and Therapeutics, Edited by F Calvo, M Crepin, H Magdelenat, Montrouge, France, John Libbey, 1996, pp 191-200
3. Ploug M, Ronne E, Behrendt N, Jensen AL, Blasi F, Dano K: Cellular receptor for urokinase plasminogen activator: carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 1991, 266:1926-1933
4. Dano K, Behrendt M, Brünner N, Ellis V, Ploug M, Pyke C: The urokinase receptor, Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994, 8:189-202
5. Duggan C, Maguire T, McDermott E, O'Higgins H, Fennelly JJ, Duffy MJ: Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer, Int J Cancer 1995, 61:597-600
6. Xing RH, Rabbani SA: Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth, and metastasis. Int J Cancer 1996, 67:423-429
7. Conese M, Blasi F: Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation. Biol Chem Hoppe-Seyler 1995, 376:143-155
8. Liu G, Shuman MA, Cohen RL: Co-expression of urokinase, urokinase receptor, and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer 1995, 60:501-506
9. Fazioli F, Blasi F: Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? Trends Pharmacol Sci 1994, 15:25-29
10. Wilhelm O, Schmitt M, Senekowitsch R, Höhl S, Wilhelm S, Will C, Rettenberger P, Reuning U, Weidle U, Magdolen V, Graeff H: The urokinase/urokinase receptor system: a new target for cancer therapy? Prospects in Diagnosis and Treatment of Breast Cancer. Excerpta Medica 1050. Edited by M Schmitt, H Graeff, G Kindermann. Amsterdam, Elsevier, 1994, pp 145-156
11. Wilhelm O, Weidle U, Höhl S, Rettenberger P, Schmitt M, Graeff H: Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA): inhibition of proliferation and invasion of human ovarian cancer cells, FEBS Lett 1994, 337:131-134
12. Magdolen V, Rettenberger P, Lopens A, Oi H, Lottspeich F, Kellermann J, Creutzburg S, Goretzki L, Weidle UH, Wilhelm O, Schmitt M, Graeff H: Expression of the human urokinase-type plasminogen activator receptor in E. coli and Chinese hamster ovary cells: purification of the recombinant proteins and generation of polyclonal antibodies in chicken. Electrophoresis 1995, 16:813-816
13. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
14. Albrecht S, Luther T, Grossmann H, Flössel C, Kotzsch M, Müller M: An ELISA for tissue factor using monoclonal antibodies. Blood Coagul Fibrinol 1992, 3:263-270
15. Barlos K, Chatzi O, Gatos D, Stavropoulos G: 2-Chlortrityl chloride resin. Int J Peptide Protein Res 1991, 37:513-520
16. Carpino LA, Han GY: The fluorenylmethoxycarbonyl amino-protecting group, J Org Chem 1972, 37:3404-3409
17. Fields GB, Noble RL: Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Peptide Protein Res 1990, 35:161-214
18. White P: Fmoc-Trp(Boc)-OH: a new derivative for the synthesis of peptides containing tryptophan. Peptides, Chemistry and Biology. Proceedings of the 12th American Peptide Symposium. Edited by JA Smith, JE River. Cambridge, MA, 1992, pp 537-538
19. Chucholowski N, Schmitt M, Rettenberger P, Schüren E, Moniwa N, Goretzki L, Wilhelm O, Weidle U, Jänicke F, Graeff H: Flow cytofluorometric analysis of the urokinase receptor (uPAR) on tumor cells by fluorescent uPA-ligand or monoclonal antibody 3936. Fibrinolysis 1992, 6:95-102
20. Luther T, Flössel C, Mackman N, Bierhaus A, Kasper M, Albrecht S, Sage EH, Iruela-Arispe L, Grossmann H, Ströhlein A, Zhang Y, Nawroth PP, Carmeliet P, Loskutoff DJ, Müller M: Tissue factor expression during human and mouse development. Am J Pathol 1996, 149: 101-113
21. Flössel C, Luther T, Müller M, Albrecht S, Kasper M: Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochemistry 1994, 101:449-453
22. Rettenberger P, Wilhelm O, Oi H, Weidle UH, Goretzki L, Koppitz M, Lottspeich F, König B, Pessara U, Kramer MD, Schmitt M, Magdolen V: A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor, Biol Chem Hoppe-Seyler 1995, 376:587-594
23. Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Dano K: The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator, J Biol Chem 1991, 266:7842-7847
24. 2-terminal amino acid sequence and glycosylation variants. J Biol Chem 1990, 265:6453-6460
25. Pyke C, Graem N, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Brunner N, Dano K: Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 1993, 53:1911-1915
26. Bianchi E, Cohen RL, Thor AT, Todd RF III, Mizukami IF, Lawrence DA, Ljung BM, Shuman MA, Smith HS: The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 1994, 54:861-866
27. Picone R, Kajtaniak EL, Nielsen LS, Behrendt N, Mastronicola MR, Cubellis MV, Stoppelli MP, Pedersen S, Dano K, Blasi F: Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate. J Cell Biol 1989, 108:693-702
28. Hoyer-Hansen G, Ronne E, Solberg H, Behrendt N, Ploug M, Lund LR, Ellis V, Dano K: Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem 1992, 267: 18224-18229
29. Solberg H, Romer J, Brünner N, Holm A, Sidenius N, Dano K, Hoyer-Hansen G: A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors. Int J Cancer 1994, 58:887-881
30. Lau HKF, Kim M, Koo J, Chiu B, Murray D: Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas. Clin Exp Metastasis 1995, 13:492-498
31. Pedersen N, Schmitt M, Ronne E, Nicoletti MI, Hoyer-Hansen G, Conese M, Giavazzi R, Dano K, Kuhn W, Jänicke F, Blasi F: A ligand-free, soluble urokinase-receptor is present in the ascitic fluid from patients with ovarian cancer, J Clin Invest 1993, 92:2160-2167
32. Bayraktutan U, Jones P: A novel urokinase receptor on monocyte-like macrophage cell line. Biochem Soc Trans 1993, 21:3955
33. Casey JR, Petranka JG, Kottra J, Fleenor DE, Rosse WF: The structure of the urokinase-type plasminogen activator receptor gene. Blood 1994, 84:1151-1156
34. Pyke C, Eriksen J, Solberg H, Schnack-Nielsen B, Kristensen P, Lund LR, Dano K: An alternatively-spliced variant of mRNA for the human receptor for urokinase plasminogen activator. FEBS Lett 1993, 326:69-73
35. Andreasen PA, Sottrup-Jensen L, Kjoller L, Nykjaer A, Moestrup SK, Petersen CM, Gliemann J: Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes, FEBS Lett 1994, 338: 239-245
36. Blasi F: Urokinase and urokinase receptor: a paracrine/ autocrine system regulating cell migration and invasiveness. Bioessays 1993, 15:105-111
37. Carriero MV, Franco P, Del-Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M: Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies, Cancer Res 1994, 54:5445-5454
38. Kanse SP, Kost C, Wilhelm OG, Andreasen P, Preissner KT: The urokinase receptor is a major vitronectin-binding protein on endothelial cells, Exp Cell Res 1996, 224:344-353
39. Schmitt M, Wilhelm O, Jänicke F, Magdolen V, Reuning U, Ohi H, Moniwa N, Kobayashi H, Weidle U, Graeff H: Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis. J Obstet Gynaecol 1995, 21:151-165
40. Ronne E, Behrendt N, Ellis V, Ploug M, Dano K, Hoyer-Hansen G: Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor. FEBS Lett 1991, 288:233-236
41. Mizukami IF, Garni-Wagner BA, DeAngelo LM, Liebert M, Flint A, Lawrence DA, Cohen RL, Todd RF III: Im- munologic detection of the cellular receptor for urokinase plasminogen activator. Clin Immunol Immunopathol 1994, 71:96-104
42. Pollänen JJ: The N-terminal domain of human urokinase receptor contains two distinct regions critical for ligand recognition. Blood 1993, 82:2719-2729
43. Ploug M, Rahbek-Nielsen H, Ellis V, Roepstorff P, Dano K: Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane: evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction. Biochemistry 1995, 34:12524-12534
44. Moller LB, Pollänen J, Ronne E, Pedersen N, Blasi F: N-linked glycosylation of the ligand binding domain of the human urokinase receptor contributes to the affinity for its ligand. J Biol Chem 1993, 268:11152-11159
45. Magdolen V, Rettenberger P, Koppitz M, Goretzki L, Kessler H, Weidle UH, König B, Graeff H, Schmitt M, Wilhelm O: Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator. Eur J Biochem 1996, 237:743-751
46. Pyke C, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Kirkeby L, Dano K: Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 1994, 24:131-138
47. Wagner SN, Atkinson MJ, Thanner S, Wagner C, Schmitt M, Wilhelm O, Rotter M, Höfler H: Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma. Am J Pathol 1995, 147: 183-192
48. Luther T, Flössel C, Albrecht S, Kotzsch M, Müller M: Tissue factor expression in normal and abnormal mammary gland, Nature Med 1996, 2:491-492
49. Konrad M, Merz WE: Regulation of N-glycosylation. J Biol Chem 1994, 269:8659-8666